Verena Muzio

Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen

JC Aguilar, Yadira Lobaina, Verena Muzio et al. · Immunology and Cell Biology · 2004 · 86 citations

Life Sciences, Immunology, Infectious Diseases +17

Heberprot-P: a novel product for treating advanced diabetic foot ulcer

Jorge Berlanga, José Ignacio Fernández Fernández, P A Reyes López et al. · MEDICC Review · 2013 · 58 citations · Full text

Health Professions, Pharmacotherapy, Surgery +13

Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen

Yadira Lobaina, Daniel Palenzuela, Dagmara Pichardo et al. · Molecular Immunology · 2004 · 46 citations

Life Sciences, Immunology, Adaptive Immunity +12

Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial

Leticia Rosario Cruz, Idania Baladrón, Aliusha Rittoles et al. · ACS Pharmacology & Translational Science · 2020 · 45 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Phase I Clinical Evaluation of a Synthetic Oligosaccharide-Protein Conjugate Vaccine against <i>Haemophilus influenzae</i> Type b in Human Adult Volunteers

Gilda Toraño, María Eugenia Toledo, Alberto Baly et al. · Clinical and Vaccine Immunology · 2006 · 35 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17